I am confident that there will be great opportunities for Allergan colleagues at Pfizer. Our integration effort will be chaired by Frank D’Amelio from Pfizer and Bob Stewart from Allergan with Sanjiv Patel serving in a leading role. The teams will work in partnership to develop the integration plans that will be executed after the close which we expect to be in the second half of 2016. Until then we will continue to operate as two separate companies.
In the meantime... nothing will change. We will continue to drive our business and I am counting on each of you to keep focused on being BOLD and driving for excellence and personal success.
Let’s continue our winning formula together.